• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Orengedoku-to augmentation in cases showing partial response to yokukan-san treatment: a case report and literature review of the evidence for use of these Kampo herbal formulae.有效改善六君子汤治疗部分应答病例的疗效:一项病例报告及对这些汉方药方剂使用证据的文献复习。
Neuropsychiatr Dis Treat. 2013;9:151-5. doi: 10.2147/NDT.S38318. Epub 2013 Jan 18.
2
Yokukan-san: a review of the evidence for use of this Kampo herbal formula in dementia and psychiatric conditions.横川-san:该汉方药在痴呆和精神疾病中的应用证据综述。
Neuropsychiatr Dis Treat. 2014 Sep 12;10:1727-42. doi: 10.2147/NDT.S65257. eCollection 2014.
3
Effectiveness and safety of the co-administration of Yokukan-San (Japanese herbal medicine) with antipsychotics in hospitalized older patients with pneumonia.Yokukan-San(日本草药)与抗精神病药物联合用于住院老年肺炎患者的疗效和安全性。
Geriatr Gerontol Int. 2023 Nov;23(11):849-854. doi: 10.1111/ggi.14696. Epub 2023 Oct 7.
4
Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.益肝散治疗抗精神病药物所致迟发性运动障碍:一项开放性研究。
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):761-4. doi: 10.1016/j.pnpbp.2007.12.003. Epub 2007 Dec 14.
5
Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.奥氮平转换为喹硫平后改善迟发性运动障碍和肌张力障碍:病例报告及文献复习。
J Clin Pharm Ther. 2012 Jun;37(3):370-2. doi: 10.1111/j.1365-2710.2011.01290.x. Epub 2011 Oct 24.
6
Kami-shoyo-san, Kampo (Japanese traditional medicine), is effective for climacteric syndrome, especially in hormone-replacement-therapy-resistant patients who strongly complain of psychological symptoms.加味逍遥散,一种日本传统中药,对更年期综合征有效,尤其适用于强烈抱怨心理症状的激素替代疗法抵抗患者。
J Obstet Gynaecol Res. 2013 Jan;39(1):223-8. doi: 10.1111/j.1447-0756.2012.01936.x. Epub 2012 Jul 6.
7
A valid approach in refractory glossodynia: a single-institution 5-year experience treating with Japanese traditional herbal (kampo) medicine.一种有效的难治性舌痛治疗方法:日本传统草药(汉方药)治疗的单机构 5 年经验。
Evid Based Complement Alternat Med. 2013;2013:354872. doi: 10.1155/2013/354872. Epub 2013 Oct 7.
8
[Clinical usage of Yi-gan san-schizophrenia, borderline personality disorder, dyskinesia etc-].[益肝散在精神分裂症、边缘性人格障碍、运动障碍等方面的临床应用]
Seishin Shinkeigaku Zasshi. 2012;114(6):708-18.
9
Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 3: Clinical Trial Data.确定阿立哌唑与重度抑郁症患者迟发性运动障碍和/或肌张力障碍之间是否存在明确的因果关系,第3部分:临床试验数据
J Psychiatr Pract. 2016 Mar;22(2):117-23. doi: 10.1097/PRA.0000000000000145.
10
Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study.益肝散作为难治性精神分裂症的辅助治疗:一项开放标签研究。
Clin Neuropharmacol. 2009 Jan-Feb;32(1):6-9. doi: 10.1097/WNF.0b013e31817e08c3.

引用本文的文献

1
Screening of the active Ingredients in Huanglian Jiedu decoction through amide bond-Immobilized magnetic nanoparticle-assisted cell membrane chromatography.通过酰胺键固定化磁性纳米颗粒辅助细胞膜色谱法筛选黄连解毒汤中的活性成分。
Front Pharmacol. 2022 Dec 19;13:1087404. doi: 10.3389/fphar.2022.1087404. eCollection 2022.
2
Involvement of Huanglian Jiedu Decoction on Microglia with Abnormal Sphingolipid Metabolism in Alzheimer's Disease.黄连解毒汤对阿尔茨海默病中小胶质细胞异常神经鞘脂代谢的作用。
Drug Des Devel Ther. 2022 Mar 30;16:931-950. doi: 10.2147/DDDT.S357061. eCollection 2022.
3
Analysis of Antidepressant Activity of Huang-Lian Jie-Du Decoction Through Network Pharmacology and Metabolomics.基于网络药理学和代谢组学的黄连解毒汤抗抑郁活性分析
Front Pharmacol. 2021 Mar 4;12:619288. doi: 10.3389/fphar.2021.619288. eCollection 2021.
4
Huanglian Jiedu decoction remodels the periphery microenvironment to inhibit Alzheimer's disease progression based on the "brain-gut" axis through multiple integrated omics.黄连解毒汤基于“脑-肠”轴通过多组学整合重塑外周微环境抑制阿尔茨海默病进展。
Alzheimers Res Ther. 2021 Feb 12;13(1):44. doi: 10.1186/s13195-021-00779-7.
5
Roles of Gut Microbiota in Pathogenesis of Alzheimer's Disease and Therapeutic Effects of Chinese Medicine.肠道微生物群在阿尔茨海默病发病机制中的作用及中药的治疗效果。
Chin J Integr Med. 2022 Nov;28(11):1048-1056. doi: 10.1007/s11655-020-3274-5. Epub 2020 Sep 1.
6
Effects of Huang-Lian-Jie-Du Decoction on Oxidative Stress and AMPK-SIRT1 Pathway in Alzheimer's Disease Rat.黄连解毒汤对阿尔茨海默病大鼠氧化应激及AMPK-SIRT1通路的影响
Evid Based Complement Alternat Med. 2020 Jan 2;2020:6212907. doi: 10.1155/2020/6212907. eCollection 2020.
7
Huang-Lian Jie-Du decoction: a review on phytochemical, pharmacological and pharmacokinetic investigations.黄连解毒汤:植物化学、药理学及药代动力学研究综述
Chin Med. 2019 Dec 18;14:57. doi: 10.1186/s13020-019-0277-2. eCollection 2019.
8
Modified Huang-Lian-Jie-Du Decoction Ameliorates A Synaptotoxicity in a Murine Model of Alzheimer's Disease.黄连解毒汤加减可改善阿尔茨海默病小鼠的突触毒性。
Oxid Med Cell Longev. 2019 Nov 3;2019:8340192. doi: 10.1155/2019/8340192. eCollection 2019.
9
Traditional Oriental Medicines and Alzheimer's Disease.传统东方医学与阿尔茨海默病
Aging Dis. 2019 Apr 1;10(2):307-328. doi: 10.14336/AD.2018.0328. eCollection 2019 Apr.
10
Hwangryunhaedok-Tang Exerts Neuropreventive Effect on Memory Impairment by Reducing Cholinergic System Dysfunction and Inflammatory Response in a Vascular Dementia Rat Model.黄药丹通过降低血管性痴呆大鼠模型胆碱能系统功能障碍和炎症反应发挥神经保护作用。
Molecules. 2019 Jan 18;24(2):343. doi: 10.3390/molecules24020343.

本文引用的文献

1
Oren-gedoku-to and its constituents with therapeutic potential in Alzheimer's disease inhibit indoleamine 2, 3-dioxygenase activity in vitro.莪术及其成分在阿尔茨海默病中的治疗潜力可抑制体外色氨酸 2,3-双加氧酶活性。
J Alzheimers Dis. 2010;22(1):257-66. doi: 10.3233/JAD-2010-100684.
2
Use of Yokukansan (TJ-54) in the treatment of neurological disorders: a review.用和汉三才汤(TJ-54)治疗神经紊乱疾病:综述。
Phytother Res. 2010 Sep;24(9):1265-70. doi: 10.1002/ptr.3146.
3
Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice.在临床实践中用和汉三才汤治疗阿尔茨海默病样痴呆的行为和心理症状。
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 16;34(3):541-5. doi: 10.1016/j.pnpbp.2010.02.016. Epub 2010 Feb 23.
4
Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease.和汉三才汤治疗阿尔茨海默病常规治疗中对痴呆行为和心理症状的影响。
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 16;34(3):532-6. doi: 10.1016/j.pnpbp.2010.02.013. Epub 2010 Feb 17.
5
Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study.益肝散作为难治性精神分裂症的辅助治疗:一项开放标签研究。
Clin Neuropharmacol. 2009 Jan-Feb;32(1):6-9. doi: 10.1097/WNF.0b013e31817e08c3.
6
Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease.yokukansan对老年阿尔茨海默病患者痴呆行为和心理症状的影响。
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):308-11. doi: 10.1016/j.pnpbp.2008.12.008. Epub 2008 Dec 24.
7
Traditional Chinese medicine on four patients with Huntington's disease.中医治疗四名亨廷顿舞蹈症患者的情况。
Mov Disord. 2009 Feb 15;24(3):453-5. doi: 10.1002/mds.22447.
8
Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.益肝散治疗抗精神病药物所致迟发性运动障碍:一项开放性研究。
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):761-4. doi: 10.1016/j.pnpbp.2007.12.003. Epub 2007 Dec 14.
9
Yi-gan san for the treatment of borderline personality disorder: an open-label study.益肝散治疗边缘型人格障碍:一项开放标签研究。
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):150-4. doi: 10.1016/j.pnpbp.2007.07.026. Epub 2007 Aug 8.
10
Reconsideration of Japanese traditional herbal medicine: new field of research and clinical medicine.
Mini Rev Med Chem. 2006 May;6(5):543-7. doi: 10.2174/138955706776876258.

有效改善六君子汤治疗部分应答病例的疗效:一项病例报告及对这些汉方药方剂使用证据的文献复习。

Orengedoku-to augmentation in cases showing partial response to yokukan-san treatment: a case report and literature review of the evidence for use of these Kampo herbal formulae.

机构信息

Department of Japanese-Oriental (Kampo) Medicine, Chiba University Graduate School of Medicine, Chiba City, Japan;

出版信息

Neuropsychiatr Dis Treat. 2013;9:151-5. doi: 10.2147/NDT.S38318. Epub 2013 Jan 18.

DOI:10.2147/NDT.S38318
PMID:23378767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3554226/
Abstract

BACKGROUND

Yokukan-san, a Japanese traditional herbal (Kampo) prescription, has recently gathered increasing attention due to accumulating reports showing its remarkable efficacy in treating a wide variety of diseases refractory to conventional medicine as well as the behavioral and psychological symptoms of dementia. As yokukan-san has become broadly integrated with conventional medicine, augmentation therapy with other Kampo prescriptions has become necessary when the yokukan-san has been only partially efficacious. In this paper, we report three cases in which the addition of orengedoku-to, another Kampo formula, to yokukan-san was remarkably effective.

CASES

Case 1 was an 85-year-old man with Alzheimer-type dementia who had become aggressive during the past 2 years. Three milligrams of aripiprazole completely suppressed his problematic behaviors but had to be stopped because of extrapyramidal symptoms. In the second case, a 44-year-old man with methamphetamine-induced psychosis had suffered from serious tardive dystonia for 2 years. No conventional approach had improved his tardive dystonia. The third case was a 29-year-old engineer who often failed to resist aggressive impulses and was diagnosed with intermittent explosive disorder. He was prescribed 5 mg of olanzapine, which did not suppress his extraordinary anger and caused somnolence even though the dose was low.

INTERVENTIONS AND OUTCOMES

Yokukan-san was complementarily added to the patients' regular medication and exerted a definitive but partial effect in all cases. The addition of orengedoku-to to yokukan-san exerted the same efficacy as aripiprazole in controlling aggressiveness in Case 1, improved the tardive dystonia by 80% in Case 2, and was completely effective in controlling the patient's aggressive impulses in Case 3.

CONCLUSION

Together with empirical evidence demonstrating the effectiveness of both yokukansan and orengedoku-to in reducing irritability, impulsivity, and aggression, these three cases suggest that orengedoku-to augmentation can be an effective option in cases that are partially responsive to yokukan-san treatment.

摘要

背景

横川散是一种日本传统草药(汉方)方剂,由于越来越多的报告显示其在治疗各种传统医学难治性疾病以及痴呆的行为和心理症状方面的显著疗效,因此受到了越来越多的关注。由于横川散已广泛与传统医学相结合,当横川散仅部分有效时,需要与其他汉方方剂联合增效治疗。在本文中,我们报告了三例加味逍遥散对横川散增效治疗的显著疗效。

病例 1 是一位 85 岁的阿尔茨海默病患者,过去 2 年来变得具有攻击性。三毫克阿立哌唑完全抑制了他的问题行为,但因出现锥体外系症状而不得不停药。在第二个病例中,一名 44 岁的男性因吸食冰毒导致精神病,已经遭受严重的迟发性运动障碍 2 年。没有任何常规方法可以改善他的迟发性运动障碍。第三个病例是一名经常无法抗拒攻击冲动的 29 岁工程师,被诊断为间歇性爆发障碍。他被开了 5 毫克奥氮平,但未能抑制他的异常愤怒,即使剂量较低,也导致了嗜睡。

干预和结果

横川散与患者的常规药物联合使用,在所有病例中都发挥了明确但部分的疗效。在病例 1 中,加味逍遥散与阿立哌唑联合使用,对控制攻击性的疗效与阿立哌唑相同;在病例 2 中,加味逍遥散改善了 80%的迟发性运动障碍;在病例 3 中,完全有效控制了患者的攻击冲动。

结论

结合横川散和加味逍遥散在减轻烦躁、冲动和攻击性方面的有效性的经验证据,这三个病例表明,加味逍遥散增效治疗可以作为对横川散治疗部分反应的有效选择。